Pharmaceutical Metoclopramide Hydrochloride Powder Chemical Metoclopramide Hydrochloride Powder Metoclopramide Hydrochloride

• CAS No.: 54143-57-6
• Formula: C14h25cl2n3o3
• EINECS: 230-634-5
• Type: Pharmaceutical Intermediates
• Appearance: Powder
• Quality: Refined
• Model NO.: D-sung Metoclopramide hydrochloride
• Colour: White
• Model No.: Dsung-Metoclopramide Hydrochloride
• Product Name: Metoclopramide Hydrochloride
• Name: Metoclopramide Hydrochloride Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anti - Vomiting
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• Molecular Formula: C14h25cl2n3o3
• Melting Point: 182.5-184 C
• Boiling Point: 418.7 Cat760mmhg
• HS Number: 2924296000
• Psa: 67.59000
• Logp: 3.77650
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• HS Code: 2924296000
• Production Capacity: 5000kg/Month

Product Description

 

Product Description

Pharmaceutical Metoclopramide hydrochloride powder  Chemical Metoclopramide hydrochloride powder Metoclopramide hydrochloride

 

Product Description

Product Details

Product Name	Metoclopramide Hydrochloride
CAS NO.	54143-57-6
Purity	99%
Melting point	182.5-184 C
Appearance and shape	White powder

Metoclopramide hydrochloride  is an antiemetic (useful in treating vomiting) and gastroprokinetic agent. It belongs to a group of medicines called ´dopaminergic´ blockers. It is commonly used to treat nausea and vomiting, to facilitate gastric emptying in people with gastroparesis, and as a treatment for the gastric stasis often associated with migraine headaches.

Application & Function

Metoclopramide hydrochloride hydrate is a dopamine D2 antagonist that is used as an antiemetic.IC50 Value:Target: D2 ReceptorMetoclopramide is a dopamine receptor antagonist which has been used for treatment of a variety of gastrointestinal symptoms over the last thirty years. In various countries, metoclopramide is the antiemetic drug of choice in pregnant women. Findings provide reassurance regarding the safety of metoclopramide for the fetus when the drug is given to women to relieve nausea and vomiting during pregnancy. Evidence also supports its use for gastroparesis (poor stomach emptying) and gastroesophageal reflux disease. It appears to bind to dopamine D2 receptors where it is a receptor antagonist, and is also a mixed 5-HT3 receptor antagonist/ 5-HT4 receptor agonist.

Specification